FDA Safety Communication: Possible Increased Risk of Cancer with Weight-loss Medicine Lorcaserin
15 Jan, 2020 | 08:02h | UTCCommentaries: CV Safety Trial for Lorcaserin Picks Up Cancer Signal: FDA – TCTMD (free) AND FDA Warning: Weight Loss Drug Belviq May Increase Cancer Risk- Forbes (free)